SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Szczurek Ewa) "

Sökning: WFRF:(Szczurek Ewa)

  • Resultat 1-7 av 7
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Adamik, Barbara, et al. (författare)
  • Estimation of the Severeness Rate, Death Rate, Household Attack Rate and the Total Number of COVID-19 Cases Based on 16 115 Polish Surveillance Records
  • 2020
  • Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
    • Background: Estimating the actual number of COVID-19 infections is crucial for steering through the COVID-19 pandemic crisis. It is, however, notoriously difficult, as many cases have no or only mild symptoms. Surveillance data for in-household secondary infections offers unbiased samples for COVID-19 prevalence estimation.Methods: We analyse 16 115 Polish surveillance records to obtain key figures of the COVID-19 pandemic. We propose conservative upper and lower bound estimators for the number of SARS-CoV-2 infections. Further, we estimate age-dependent bounds on the severe case rate, death rate, and the in-household attack rate.Results: By maximum likelihood estimates, the total number of COVID-19 cases in Poland as of July 22nd, 2020, is at most around 13 times larger and at least 1.6 times larger than the recorded number. The lower bound on the severeness rate ranges between 0.2% for the 0–39 year-old to 5.7% for older than 80, while the upper bound is between 2.6% and 34.1%. The lower bound on the death rate is between 0.04% for the age group 40–59 to 1.34% for the oldest. Overall, the severeness and death rates grow exponentially with age. The in-household attack ratio is 8.18% for the youngest group and 16.88% for the oldest.Conclusions: The proposed approach derives highly relevant figures on the COVID-19 pandemic from routine surveillance data, under assumption that household members of detected infected are tested and all severe cases are diagnosed.
  •  
2.
  • Czypionka, Thomas, et al. (författare)
  • The benefits, costs and feasibility of a low incidence COVID-19 strategy
  • 2022
  • Ingår i: The Lancet Regional Health. - : Elsevier. - 2666-7762. ; 13
  • Tidskriftsartikel (refereegranskat)abstract
    • In the summer of 2021, European governments removed most NPIs after experiencing prolonged second and third waves of the COVID-19 pandemic. Most countries failed to achieve immunization rates high enough to avoid resurgence of the virus. Public health strategies for autumn and winter 2021 have ranged from countries aiming at low incidence by re-introducing NPIs to accepting high incidence levels. However, such high incidence strategies almost certainly lead to the very consequences that they seek to avoid: restrictions that harm people and economies. At high incidence, the important pandemic containment measure test-trace-isolate-support becomes inefficient. At that point, the spread of SARS-CoV-2 and its numerous harmful consequences can likely only be controlled through restrictions. We argue that all European countries need to pursue a low incidence strategy in a coordinated manner. Such an endeavour can only be successful if it is built on open communication and trust. Copyright (C) 2021 The Authors. Published by Elsevier Ltd.
  •  
3.
  • Geras, Agnieszka, et al. (författare)
  • Celloscope : a probabilistic model for marker-gene-driven cell type deconvolution in spatial transcriptomics data
  • 2023
  • Ingår i: Genome Biology. - : Springer Nature. - 1465-6906 .- 1474-760X. ; 24:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Spatial transcriptomics maps gene expression across tissues, posing the challenge of determining the spatial arrangement of different cell types. However, spatial transcriptomics spots contain multiple cells. Therefore, the observed signal comes from mixtures of cells of different types. Here, we propose an innovative probabilistic model, Celloscope, that utilizes established prior knowledge on marker genes for cell type deconvolution from spatial transcriptomics data. Celloscope outperforms other methods on simulated data, successfully indicates known brain structures and spatially distinguishes between inhibitory and excitatory neuron types based in mouse brain tissue, and dissects large heterogeneity of immune infiltrate composition in prostate gland tissue.
  •  
4.
  • Iftekhar, Emil Nafis, et al. (författare)
  • A look into the future of the COVID-19 pandemic in Europe : an expert consultation
  • 2021
  • Ingår i: The Lancet Regional Health. - : Elsevier. - 2666-7762. ; 8
  • Tidskriftsartikel (refereegranskat)abstract
    • How will the coronavirus disease 2019 (COVID-19) pandemic develop in the coming months and years? Based on an expert survey, we examine key aspects that are likely to influence the COVID-19 pandemic in Europe. The challenges and developments will strongly depend on the progress of national and global vaccination programs, the emergence and spread of variants of concern (VOCs), and public responses to non-pharmaceutical interventions (NPIs). In the short term, many people remain unvaccinated, VOCs continue to emerge and spread, and mobility and population mixing are expected to increase. Therefore, lifting restrictions too much and too early risk another damaging wave. This challenge remains despite the reduced opportunities for transmission given vaccination progress and reduced indoor mixing in summer 2021. In autumn 2021, increased indoor activity might accelerate the spread again, whilst a necessary reintroduction of NPIs might be too slow. The incidence may strongly rise again, possibly filling intensive care units, if vaccination levels are not high enough. A moderate, adaptive level of NPIs will thus remain necessary. These epidemiological aspects combined with economic, social, and health-related consequences provide a more holistic perspective on the future of the COVID-19 pandemic.
  •  
5.
  • Pierzynowski, Stefan G., et al. (författare)
  • Difference in Performance of EPI Pigs Fed Either Lipase-Predigested or Creon®-Supplemented Semielemental Diet
  • 2021
  • Ingår i: BioMed Research International. - : Hindawi Limited. - 2314-6133 .- 2314-6141. ; 2021
  • Tidskriftsartikel (refereegranskat)abstract
    • Pancreatic enzyme replacement therapy (PERT) and fat predigestion are key in ensuring the optimal growth of patients with cystic fibrosis. Our study attempted to highlight differences between fat predigestion and conventional PERT on body composition of young pigs with exocrine pancreatic insufficiency (EPI). EPI and healthy pigs were fed with high-fat diet for six weeks. During the last two weeks of the study, all pigs received additional nocturnal alimentation with Peptamen AF (PAF) and were divided into three groups: H - healthy pigs receiving PAF; P - EPI pigs receiving PAF+PERT; and L - EPI pigs receiving PAF predigested with an immobilized microbial lipase. Additional nocturnal alimentation increased the body weight gain of EPI pigs with better efficacy in P pigs. Humerus length and area in pigs in groups L and P were lower than that observed in pigs in group H (p value 0.005-0.088). However, bone mineral density and strength were significantly higher in P and L as compared to that of H pigs (p value 0.0026-0.0739). The gut structure was improved in P pigs. The levels of neurospecific proteins measured in the brain were mainly affected in P and less in L pigs as compared to H pigs. The beneficial effects of the nocturnal feeding with the semielemental diet in the prevention of EPI pigs' growth/development retardation are differently modified by PERT or fat predigestion in terms of growth, bone properties, neurospecific protein distribution, and gut structure.
  •  
6.
  •  
7.
  • Szczurek, Paulina, et al. (författare)
  • Oral uricase eliminates blood uric acid in the hyperuricemic pig model
  • 2017
  • Ingår i: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 12:6
  • Tidskriftsartikel (refereegranskat)abstract
    • An elevated level of serum uric acid - hyperuricemia, is strongly associated with the development of gout and chronic kidney disease (CKD) which is often accompanied by a significantly reduced glomerular filtration rate (GFR). In the present study, we investigated the extra-renal elimination of uric acid via the intestine in a healthy pig model and the effect of oral uricase therapy on plasma uric acid concentrations in pigs with induced hyperuricemia and CKD. The experiment was conducted on eleven, ten-week-old pigs (n = 11). The porcine model of CKD was developed by performing 9/10 nephrectomy surgery on eight pigs. A stable model of hyperuricemia was established in only five of the eight nephrectomized pigs by frequent injections of uric acid (UA) into the jugular vein. All pigs (three healthy pigs and five CKD pigs) were operated for implantation of jugular vein catheters and the three healthy pigs also had portal vein catheters inserted. Blood uric acid concentrations were measured spectrophotometrically, using the Uric Acid Assay Kit (BioAssay Systems, Hayward, USA). The piglets with CKD received orally administered uricase (treatment) and served as their own controls (without uricase supplementation). Oral uricase therapy significantly decreased plasma uric acid concentrations in pigs with CKD, whereas hyperuricemia was observed in the pigs whilst not being treated with uricase. Urinary uric acid excretion was similar during both the treatment and control periods during the first 8 h and 24 h after UA infusions in the CKD pigs. To demonstrate the elimination of UA via the intestine, the healthy pigs were infused with UA into the jugular vein. The blood collected from the jugular vein represents circulating UA concentrations and the blood collected from the portal vein represents the concentration of UA leaving the intestine. The final (after 2 h) concentration of UA was significantly lower in blood collected from the portal vein compared to that collected from the jugular vein (3.34 vs. 2.43 mg/dL, respectively, p = 0.024). The latter allows us to suggest that UA is eliminated from the blood via the gut tissue.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-7 av 7
Typ av publikation
tidskriftsartikel (6)
annan publikation (1)
Typ av innehåll
refereegranskat (5)
övrigt vetenskapligt/konstnärligt (2)
Författare/redaktör
Szczurek, Ewa (5)
Martins, Carlos (3)
Bauer, Simon (3)
Prainsack, Barbara (3)
Machado, Helena (3)
Schernhammer, Eva (3)
visa fler...
Czypionka, Thomas (3)
Priesemann, Viola (3)
Cuschieri, Sarah (3)
Glaab, Enrico (3)
Grill, Eva (3)
Krutzinna, Jenny (3)
Perc, Matjaz (3)
Petelos, Elena (3)
Pickersgill, Martyn (3)
Tsiodras, Sotirios (3)
Willeit, Peter (3)
McKee, Martin (2)
Rocklöv, Joacim, Pro ... (2)
Balling, Rudi (2)
Pavlakis, George N. (2)
Lionis, Christos (2)
Dumpis, Uga (2)
Iftekhar, Emil N. (2)
Valdez, Andre Calero (2)
Bock, Wolfgang (1)
Lagergren, Jens (1)
Adamik, Barbara (1)
Bawiec, Marek (1)
Bezborodov, Viktor (1)
Biecek, Przemyslaw (1)
Bodych, Marcin (1)
Burgard, Jan Pablo (1)
Krueger, Tyll (1)
Migalska, Agata (1)
Mocos, I. R. G. (1)
Ozanski, Thomasz (1)
Pabjan, Barbara (1)
Rosinska, Magdalena (1)
Sadkowska-Todys, Mal ... (1)
Sobczyk, Piotr (1)
Pierzynowski, Stefan ... (1)
Hanson, Claudia (1)
Wilmes, Paul (1)
Sobol, Monika (1)
Low, Nicola (1)
Staines, Anthony (1)
Klimek, Peter (1)
Skupin, Alexander (1)
Toosi, Hosein (1)
visa färre...
Lärosäte
Umeå universitet (2)
Linköpings universitet (2)
Lunds universitet (2)
Kungliga Tekniska Högskolan (1)
Linnéuniversitetet (1)
Karolinska Institutet (1)
Språk
Engelska (7)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (5)
Naturvetenskap (2)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy